Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Bolsa de valores de Sao Paulo  >  Fleury SA    FLRY3   BRFLRYACNOR5

FLEURY SA (FLRY3)

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Fleury : Payment of dividends

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/10/2017 | 06:41am CET

Payment of Dividends

Grupo Fleury informs to its shareholders that, as resolved at the board of Director meeting held on December 08th, 2017, was approved the distribution of interim dividend.

The proceeds will be distributed as interim dividends, in the total amount of R$ 71,132,641.50 (Seventy-one million, one hundred and thirty-two thousand, six hundred and forty-one reais and fifty cents), according to balance sheet as of December 31, 2016, to be calculated towards the minimum mandatory dividends for fiscal year 2016.

Credit and payment are subject to the following conditions:

The amount described above will be based on the shareholding position at the close of BM&FBOVESPA's March 14th, 2017, trading session ('record date'), and the company's shares shall be traded ex-rights as from and including March 15th , 2017 ('ex-date').

The afore mentioned payment shall be made on March 28th , 2017.

The payments related to the shares at the BM&FBovespa's custody will be made to the custodian, which is responsible to transfer the value to the corresponding shareholder.

To the other shareholders, payment will be made in accordance to the record in Banco Bradesco S.A., the Depositary Institution of the shares issued by the company. Shareholders receiving through Bradesco S.A shall keep records updated to receive the payment.

Fleury SA published this content on 10 March 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 10 March 2017 05:40:14 UTC.

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FLEURY SA
03/10 FLEURY : Payment of dividends
2016 FLEURY : Payment of Dividends and Interest on Shareholders’ Equity
2016 FLEURY : Grupo Fleury announces its 3Q16 results schedule and quiet period
2016 NOTICE TO THE MARKET : reduction of ownership participation
2016 COMUNICADO AO MEFRCADO : redução de participação da Invesco
2016 FLEURY : Grupo Fleury launches the new version of the Investor Relations website
2016 FLEURY : Grupo Fleury integrates IBrX100 portfolio
2016 FLEURY : Financial Statements - 2Q16
2016 MATERIAL FACT : Stock Option Plan
2016 FLEURY : Financial Statements - 1Q16
More news
Sector news : Medical & Diagnostic Laboratories
03/07 Drugmaker shares slip as Trump tweets about pricing system
02/23DJIHH HEALTHCARE BHD : Malaysia's IHH Healthcare Swings to Net Loss in 4th Quarter..
02/23DJIHH HEALTHCARE BHD : Malaysia's IHH Healthcare Swings to Loss in 4th Quarter
02/22DJFRESENIUS MEDICAL CARE : Profit Lifted by Strong U.S. Performance
02/21 HSBC pulls FTSE lower
More sector news : Medical & Diagnostic Laboratories
Advertisement
Financials ( BRL)
Sales 2017 2 361 M
EBIT 2017 422 M
Net income 2017 281 M
Debt 2017 191 M
Yield 2017 1,63%
P/E ratio 2017 23,81
P/E ratio 2018 20,22
EV / Sales 2017 2,87x
EV / Sales 2018 2,51x
Capitalization 6 586 M
More Financials
Chart FLEURY SA
Duration : Period :
Fleury SA Technical Analysis Chart | FLRY3 | BRFLRYACNOR5 | 4-Traders
Full-screen chart
Technical analysis trends FLEURY SA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Average target price 44,6  BRL
Spread / Average Target 6,3%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Carlos Alberto Iwata Marinelli Chief Executive Officer
Marcos Bosi Ferraz Chairman
Claudio Almeida Prado Executive Director-Operations Support
Adolpho Cyriaco Nune de Souza Neto Chief Finance Officer & Head-Investor Relations
Jeane Tsutsui Executive Director-Medical & Technical
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
FLEURY SA17.08%2 137
SONIC HEALTHCARE LIMIT..0.23%6 751
DR. LAL PATHLABS LTD-11.82%1 198
BML INC-11.88%980
NEOGENOMICS, INC.-10.74%603
RADNET INC.-12.40%267
More Results